Adler LA

References (2)

Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715
Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD
Ref : Psychopharmacology (Berl) , 219 :715 , 2012
Abstract : Apostol_2012_Psychopharmacology.(Berl)_219_715
ESTHER : Apostol_2012_Psychopharmacology.(Berl)_219_715
PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715
PubMedID: 21748252

Title : ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit\/hyperactivity disorder in adults: results of a pilot study - Wilens_2006_Biol.Psychiatry_59_1065
Author(s) : Wilens TE , Verlinden MH , Adler LA , Wozniak PJ , West SA
Ref : Biological Psychiatry , 59 :1065 , 2006
Abstract : Wilens_2006_Biol.Psychiatry_59_1065
ESTHER : Wilens_2006_Biol.Psychiatry_59_1065
PubMedSearch : Wilens_2006_Biol.Psychiatry_59_1065
PubMedID: 16499880